Revance Therapeutics shares owned by Ameriprise Financial
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Ameriprise Financial
from 13F filings
Historical chart of Ameriprise Financial investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by Ameriprise Financial
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $1.4M | 126k | 11.47 |
2023-06-30 | $5.4M | 213k | 25.31 |
2023-03-31 | $9.1M | 281k | 32.21 |
2022-12-31 | $4.3M | 234k | 18.46 |
2022-09-30 | $4.5M | 168k | 27.00 |
2022-06-30 | $2.0M | 143k | 13.82 |
2022-03-31 | $2.6M | 135k | 19.50 |
2021-12-31 | $2.0M | 121k | 16.32 |
2021-09-30 | $4.6M | 166k | 27.86 |
2021-06-30 | $4.9M | 166k | 29.64 |
2021-03-31 | $4.2M | 150k | 27.94 |
2020-12-31 | $4.5M | 160k | 28.33 |
2020-09-30 | $3.3M | 133k | 25.14 |
2020-06-30 | $3.6M | 148k | 24.42 |
2020-03-31 | $2.9M | 196k | 14.80 |
2019-12-31 | $3.5M | 217k | 16.23 |
2019-09-30 | $1.9M | 147k | 13.00 |
2019-06-30 | $1.5M | 118k | 12.97 |
2019-03-31 | $2.1M | 136k | 15.75 |
2018-12-31 | $617k | 31k | 20.15 |
2018-09-30 | $733k | 30k | 24.85 |
2018-06-30 | $744k | 27k | 27.44 |
2018-03-31 | $1.7M | 56k | 30.81 |
2017-12-31 | $2.3M | 65k | 35.74 |
2017-09-30 | $634k | 23k | 27.57 |
2017-06-30 | $604k | 23k | 26.38 |
2017-03-31 | $472k | 23k | 20.81 |
2016-12-31 | $469k | 23k | 20.68 |
2016-03-31 | $241k | 14k | 17.44 |
2015-12-31 | $1.4M | 42k | 34.15 |
2014-12-31 | $4.3M | 253k | 16.94 |
2014-09-30 | $4.5M | 235k | 19.33 |
2014-06-30 | $6.3M | 184k | 34.00 |
2014-03-31 | $5.2M | 165k | 31.50 |